Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.

@article{Zisook1998TreatmentOM,
  title={Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.},
  author={Sidney Zisook and Jane Peterkin and Kathleen J. Goggin and P A Sledge and Joseph Hampton Atkinson and Igor Grant},
  journal={The Journal of clinical psychiatry},
  year={1998},
  volume={59 5},
  pages={
          217-24
        }
}
BACKGROUND The purpose of this randomized double-blind, placebo-controlled study was to compare the efficacy and safety of fluoxetine plus group psychotherapy versus group psychotherapy alone in HIV-seropositive men (based on 1986 CDC classes II, III, and IV.C.2) who had been diagnosed with major depressive disorder (DSM-III-R). METHOD During a 7-week trial, patients were treated with fluoxetine 20-60 mg or placebo 1-3 capsules per day and were seen in weekly supportive group psychotherapy… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS